相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo
Ling Li et al.
CYTOKINE (2009)
Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension
Ana Barac et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus
Gokhan Erdem et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol
Hua Jin et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Is visfatin an adipokine or myokine?: Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens
Susan M. Krzysik-Walker et al.
ENDOCRINOLOGY (2008)
The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women
Ching-Chu Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance
Teoman Dogru et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes
Angela M. Bodles et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Serum visfatin increases with progressive β-cell deterioration
Abel Lopez-Bermejo et al.
DIABETES (2006)
The visfatin gene is associated with glucose and lipid metabolism in a Chinese population
W. -X. Jian et al.
DIABETIC MEDICINE (2006)
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding
DG Haider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Visfatin is an adipokine, but it is not regulated by thiazolidinediones
A Hammarstedt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
MP Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Mice lacking ghrelin receptors resist the development of diet-induced obesity
JM Zigman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Adipose tissue: a regulator of inflammation
CE Juge-Aubry et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF rats
KC Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
J Berndt et al.
DIABETES (2005)
Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes
S Kralisch et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes
JPH Van Wijk et al.
DIABETES CARE (2005)
The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus
HS Jung et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients
Y Miyazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-α and TNF soluble receptors in women with overweight and obesity
M Olszanecka-Glinianowicz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Abdominal obesity, muscle composition, and insulin resistance in premenopausal women
R Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Metabolic syndrome - Pathophysiology and implications for management of cardiovascular disease
G Reaven
CIRCULATION (2002)
Serum concentrations of TNF-α and soluble TNF-α receptors in obesity
B Zahorska-Markiewicz et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
分享论文
